Digest Network Come funziona
Network
/
Società
Al
Non verificato

Alto Neuroscience, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VariePsichiatriaSalute

43 comunicati stampa

Guarda tutti i comunicati
11/05/2026
Eventi
Web e Social Network
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
Fonte
Alto Neuroscience, Inc.
Emittente
Business Wire
1.00
0
04/05/2026
Fiere
Industria
Eventi
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Alto Neuroscience Presents Phase 2a Data for ALTO-207 in Major Depressive Disorder at SOBP Annual Meeting
Fonte
Alto Neuroscience, Inc.
Emittente
Business Wire
1.00
0
21/04/2026
Industria
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression
Fonte
Alto Neuroscience, Inc.
Emittente
Business Wire
1.00
0
01/04/2026
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Alto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline Advancements
Fonte
Alto Neuroscience, Inc.
Emittente
Business Wire
1.00
0
16/03/2026
Finanza
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Alto Neuroscience Announces $120 Million Private Placement Financing
Fonte
Alto Neuroscience, Inc.
Emittente
Business Wire
1.00
0
16/03/2026
Mercato azionario
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Alto Neuroscience Reports Full Year 2025 Financial Results and Recent Business Highlights
Fonte
Alto Neuroscience, Inc.
Emittente
Business Wire
1.00
0
13/03/2026
Fiere
Web e Social Network
Biotecnologia
Igiene alimentare
Sanità
Salute
Farmaceutica
Psichiatria
Scienza
Medicina - Varie
Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum
Fonte
Alto Neuroscience, Inc.
Emittente
Business Wire
1.00
0
23/02/2026
Eventi
Web e Social Network
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
Fonte
Alto Neuroscience, Inc.
Emittente
Business Wire
1.00
0
13/02/2026
Scienza
Psichiatria
Medicina - Varie
Associazioni/Professionisti
Biotecnologia
Farmaceutica
Salute
Industria
Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia
Fonte
Alto Neuroscience, Inc.
Emittente
Business Wire
1.00
0
03/02/2026
Biotecnologia
Psichiatria
Salute
Farmaceutica
Industria
Alto Neuroscience Highlights Invited Review in American Journal of Psychiatry Establishing Neuroplasticity as a Core Driver of Psychiatric Disease and Treatment
Fonte
Alto Neuroscience, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0